Cargando…

Effects of COVID-19 on diabetes care among dutch diabetes outpatients

AIMS: The COVID-19 pandemic impacted diabetes care by reducing diabetes outpatient visits and diabetes-related screening due to allocation of healthcare resources. Yet the impact of COVID-19 on diabetes outpatients has not been extensively evaluated. This study aimed to assess the effect of the COVI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bak, Jessica C.G., Serné, Erik H., Groenwold, Rolf H.H., de Valk, Harold W., Kramer, Mark H.H., Nieuwdorp, Max, Verheugt, Carianne L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563332/ https://www.ncbi.nlm.nih.gov/pubmed/37817214 http://dx.doi.org/10.1186/s13098-023-01169-9

Ejemplares similares

Gender gaps in type 1 diabetes care
por: Bak, Jessica C. G., et al.
Publicado: (2023)

DPARD: rationale, design and initial results from the Dutch national diabetes registry
por: Bak, Jessica C. G., et al.
Publicado: (2021)

National diabetes registries: do they make a difference?
por: Bak, Jessica C. G., et al.
Publicado: (2020)

Landelijke diabetesregistratie DPARD: vijf jaar succesvol op weg
por: de Vries, Silvia A. G., et al.
Publicado: (2023)

Healthcare expenditure and technology use in pediatric diabetes care
por: de Vries, Silvia A. G., et al.
Publicado: (2023)

Do sex differences in paediatric type 1 diabetes care exist? A systematic review
por: de Vries, Silvia A. G., et al.
Publicado: (2023)

Sensitivity analysis for random measurement error using regression calibration and simulation-extrapolation
por: Nab, Linda, et al.
Publicado: (2021)

Design and rationale of the IN CONTROL trial: the effects of real-time continuous glucose monitoring on glycemia and quality of life in patients with type 1 diabetes mellitus and impaired awareness of hypoglycemia
por: van Beers, Cornelis A.J., et al.
Publicado: (2015)

Mechanisms underlying the blood pressure lowering effects of dapagliflozin, exenatide, and their combination in people with type 2 diabetes: a secondary analysis of a randomized trial
por: van Ruiten, Charlotte C., et al.
Publicado: (2022)

Biliary effects of liraglutide and sitagliptin, a 12‐week randomized placebo‐controlled trial in type 2 diabetes patients
por: Smits, Mark M., et al.
Publicado: (2016)

Learning styles and preferences for live and distance education: an example of a specialisation course in epidemiology
por: Groenwold, Rolf HH, et al.
Publicado: (2013)

Amiodarone use and the risk of acute pancreatitis: Influence of different exposure definitions
por: Hempenius, Mirjam, et al.
Publicado: (2019)

Investigating Risk Adjustment Methods for Health Care Provider Profiling When Observations are Scarce or Events Rare
por: Brakenhoff, Timo B, et al.
Publicado: (2018)

Defining and improving quality management in Dutch diabetes care groups and outpatient clinics: design of the study
por: Campmans-Kuijpers, Marjo JE, et al.
Publicado: (2013)

Negative controls: Concepts and caveats
por: Penning de Vries, Bas BL, et al.
Publicado: (2023)

A systematic literature review on the efficacy–effectiveness gap: comparison of randomized controlled trials and observational studies of glucose-lowering drugs
por: Ankarfeldt, Mikkel Z, et al.
Publicado: (2017)

Validation of PROMIS Physical Function for Evaluating Outcome After Acute Achilles Tendon Rupture
por: Ochen, Yassine, et al.
Publicado: (2021)

Primary nonadherence to drugs prescribed by general practitioners: A Dutch database study
por: Hempenius, Mirjam, et al.
Publicado: (2022)

A weighting method for simultaneous adjustment for confounding and joint exposure-outcome misclassifications
por: Penning de Vries, Bas BL, et al.
Publicado: (2020)

Assessment of channeling bias among initiators of glucose-lowering drugs: A UK cohort study
por: Ankarfeldt, Mikkel Z, et al.
Publicado: (2017)

Pre-hospital and hospital delay in patients with non-ST elevation acute coronary syndromes in tertiary care
por: Youssef, G.S., et al.
Publicado: (2017)

Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39:2042–2050
por: Tonneijck, Lennart, et al.
Publicado: (2019)

Plasma uric acid and renal haemodynamics in type 2 diabetes patients
por: Suijk, Danii LS, et al.
Publicado: (2019)

Diabetes quality management in Dutch care groups and outpatient clinics: a cross-sectional study
por: Campmans-Kuijpers, Marjo JE, et al.
Publicado: (2014)

Characteristics associated with polypharmacy in people with type 2 diabetes: the Dutch Diabetes Pearl cohort
por: van Oort, S., et al.
Publicado: (2020)

Subgroup effects despite homogeneous heterogeneity test results
por: Groenwold, Rolf HH, et al.
Publicado: (2010)

Quality of diabetes care in Dutch care groups: no differences between diabetes patients with and without co-morbidity
por: de Bruin, Simone R., et al.
Publicado: (2013)

Diagnosis of COVID-19: facts and challenges
por: Zalzala, H.H.
Publicado: (2020)

M-VI Laboratory tools for diagnosis and monitoring of hepatitis C virus infection
por: Kessler, H.H.
Publicado: (2009)

Un cinquantenaire : La mort de charles nicolle et le “destin des maladies infectieuses”
por: Mollaret, H.H.
Publicado: (1986)

Transcriptomics in type 2 diabetes: Bridging the gap between genotype and phenotype
por: Jenkinson, Christopher P., et al.
Publicado: (2015)

Effects of Dapagliflozin and Combination Therapy With Exenatide on Food-Cue Induced Brain Activation in Patients With Type 2 Diabetes
por: van Ruiten, Charlotte C, et al.
Publicado: (2022)

Effects of CPAP on Blood Pressure and Sympathetic Activity in Patients With Diabetes Mellitus, Chronic Kidney Disease, and Resistant Hypertension
por: Ruzicka, Marcel, et al.
Publicado: (2020)

Outpatient costs in pharmaceutically treated diabetes patients with and without a diagnosis of depression in a Dutch primary care setting
por: Bosmans, Judith E, et al.
Publicado: (2012)

Combination therapy with exenatide decreases the dapagliflozin‐induced changes in brain responses to anticipation and consumption of palatable food in patients with type 2 diabetes: A randomized controlled trial
por: van Ruiten, Charlotte C., et al.
Publicado: (2022)

Meta-analyses triggered by previous (false-)significant findings: problems and solutions
por: Schuit, Ewoud, et al.
Publicado: (2015)

Is HbA1c a good diagnostic test for (pre)diabetes in cardiac rehabilitation patients?
por: Smulders, Yvo, et al.
Publicado: (2018)

PIV-1 Respifinderplus for the diagnostics of respiratory infections with a focus on the 2009 A/H1N1 pandemic
por: Dumoulin, A., et al.
Publicado: (2009)

Similar Adverse Pregnancy Outcome in Native and Nonnative Dutch Women with Pregestational Type 2 Diabetes: A Multicentre Retrospective Study
por: Groen, Bart, et al.
Publicado: (2013)

M-V Test validation and accreditation in the clinical virology laboratory
por: Rabenau, H.F., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_4o9pulrafvrlml9vsb5an4uq5e